BioMed Research International / 2018 / Article / Tab 3

Research Article

Health-Related Quality of Life among Women Breast Cancer Patients in Eastern China

Table 3

Quality of life scores (mean ± SD) by TNM stage, type of treatment.

EORTC ItemsTNM stagePType of treatmentP
0-IIIIIIIVChemotherapy onlyOthers

Panel A: QLQ-C30 Questionnaire

 GHS55.1±13.354.0±15.852.6±15.153.9±14.00.49751.8±12.855.6±15.9<0.001
Functional scales
 PF75.5±17.278.5±15.174.4±18.073.0±18.40.06878.5±16.272.8±17.7<0.001
 RF76.9±25.081.1±25.276.2±25.474.4±27.50.11281.0±23.374.1±27.00.001
 EF75.0±18.377.0±19.572.3±20.672.7±20.30.17075.9±18.772.7±20.50.052
 CF78.2±18.179.2±17.474.8±21.875.3±18.70.30379.0±18.374.9±20.30.012
 SF71.5±25.871.8±22.868.6±25.366.2±22.60.18071.5±23.568.5±25.50.118
Symptom scales
 FA34.4±16.430.9±18.335.0±18.536.2±19.80.01732.0±16.135.8±19.50.016
 NV19.5±21.214.0±18.620.9±23.221.7±20.70.01015.0±19.122.6±22.8<0.001
 DI10.5±18.27.5±16.112.2±21.510.5±16.50.2117.5±16.013.0±20.80.001
 FI33.9±31.033.6±28.035.0±27.637.4±27.70.56833.6±26.835.6±30.20.545
 PA29.4±18.825.0±19.530.3±20.630.8±20.00.02526.1±18.731.3±20.50.001
 DY17.9±21.712.2±18.019.1±23.719.6±25.40.03912.7±19.321.2±23.9<0.001
 SL32.2±24.226.8±22.532.7±24.634.7±26.90.09230.2±24.132.5±24.60.225
 AP23.6±23.418.3±23.026.6±26.728.8±27.90.00921.5±23.426.3±26.70.038
 CO26.5±26.619.0±23.326.6±28.025.1±25.30.04823.0±26.126.0±26.60.136

Panel B: QLQ-BR23 Questionnaire

Functional scales
 BRBI65.2±24.367.6±26.462.9±24.864.8±24.40.35565.9±25.964.0±24.20.090
 BRSEF87.1±16.591.1±15.789.2±15.788.6±15.20.08192.4±14.085.9±16.9<0.001
 BRFU51.0±31.553.5±33.949.7±30.953.9±27.60.60051.4±30.851.6±32.00.902
 BRSEE87.5±18.191.2±17.887.6±21.687.2±19.70.15392.8±14.684.3±22.4<0.001
Symptom scales
 BRST24.8±16.221.8±15.726.5±17.824.8±17.10.09723.0±15.626.3±17.80.023
 BRBS17.1±18.613.2±16.918.6±21.520.3±21.80.07514.6±19.519.4±19.8<0.001
 BRAS20.4±18.417.2±18.520.7±20.824.2±20.60.08317.8±19.622.4±19.40.001
 BRHL38.6±30.537.8±32.140.3±29.934.7±27.30.56239.7±30.337.6±30.30.450

SD, standard deviation.
GHS, global health status; PF, physical functioning; RF, role functioning; EF, emotional functioning; CF, cognitive functioning.
SF, social functioning; FA, fatigue; NV, nausea and vomiting; DI, diarrhoea; FI, financial difficulties; PA, pain; DY, dyspnoea.
SL, insomnia; AP, appetite loss; CO, constipation; BRBI, body image; BRSEF, sexual functioning; BRFU, future perspective.
BRSEE, sexual enjoyment; BRST, systemic therapy side effect; BRBS, breast symptoms; BRAS, arm symptoms; BRHL, upset by hair loss.